Article citationsMore>>
Meschi, S., Matusali, G., Colavita, F., Lapa, D., Bordi, L., Puro, V., et al. (2021) Predicting the Protective Humoral Response to a SARS-CoV-2 mRNA Vaccine. Clinical Chemistry and Laboratory Medicine, 59, 2010-2018.
https://doi.org/10.1515/cclm-2021-0700
has been cited by the following article:
-
TITLE:
Waning of Anti-Spike IgG Antibody Titer after COVID-19 Vaccination: Myth or Reality?
AUTHORS:
Laurent Dupoirieux
KEYWORDS:
SARS-CoV-2, COVID-19 Vaccines, Anti-Spike IgG Antibodies
JOURNAL NAME:
Journal of Biosciences and Medicines,
Vol.11 No.8,
August
8,
2023
ABSTRACT: This observational prospective study was conducted on 25 patients who had received a full 3-dose COVID-19 vaccination scheme with a follow-up ranging from 12 to 19 months after the last injection. The aim of the study was focused on a single biological indicator the anti-spike IgG antibody titer. The age of the patients ranged from 51 to 85 years old. 15 out 25 patients (60%) presented a comorbidity. Our data showed a persistent positive anti-spike IgG antibodies titer ranging from 105 to 5680 BAU/mL (mean: 2661 BAU/mL) in all patients. In view of these results, systematic administration of a SARS-CoV-2 vaccine booster is questionable and should be individually tailored according to the patient medical condition and the anti-spike IgG antibody level.
Related Articles:
-
Jing Zhang, Ying Sun, Zhenxing Zhu, Jingtong Zheng
-
Zameer Shervani, Intazam Khan, Umair Yaqub Qazi
-
Marcus Vinicius de Mello Pinto, Carlos Henrique Machado Bittencourt Silva, Aline Ronis Sampaio, Miriam Viviane Baron, Alexandre Gomes Sancho, Esteban Fortuny, Lizia Fabiola Almeida Silva, Felice Picariello, Rogério Mendonça de Carvalho
-
Bertha A. Ocholla, Obed Nyangena, Herbert K. Murayi, Jane W. Mwangi, Steve K. Belle, Phanice Ondeko, Rebecca Kendagor
-
Anya Vaish, James McSwiggen